Q2 revenue up 22%, PAT up 81%; 2:1 bonus and Rs 7 interim dividend

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults View source PDF Explain this filing

THYROCARE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.3%Reaction day

₹421.50

prior close

₹483.30

announcement price

After-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)+1.0%-3.3% vs market

Healthcare Service Provider peers, median of 22sector-0.2%-2.2% vs sector

On the reaction day the stock moved 3.3 pts less than Nifty Microcap 250 and 2.2 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-4.5

10m

-5.4

15m

-6.6

30m

-8.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.3+1.0-3.3-0.2-2.2

Next day

+0.3+1.5-1.3-0.4+0.6

-1.2+1.0-2.2+0.2-1.3

-1.7+2.0-3.7-0.9-0.8

-0.4+3.1-3.4-1.1+0.8

-1.1+2.6-3.7-2.0+0.9

+1.9+2.7-0.7-1.9+3.8

15d

+9.5+1.8+7.7-3.6+13.1

+23.0+2.5+20.5-2.9+25.9

+3.2-2.9+6.0-9.9+13.0

+9.2-6.3+15.5-10.7+19.9

UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 22Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Thyrocare's consolidated Q2 FY26 revenue rose 22% to Rs 216.53 crore and net profit jumped 81% to Rs 47.81 crore; H1 revenue was Rs 409.56 crore and net profit Rs 86.10 crore. Auditors gave an unmodified review. Board declared Rs 7 interim dividend (record date October 24, 2025) and recommended a 2:1 bonus of about 10.61 crore new shares, subject to shareholder approval.

Likely market impact

Strong growth and a generous dividend plus 2:1 bonus should support investor sentiment, though the bonus is not yet approved.